NS PHARMA
NS Pharma Develops treatments that offer value to those living with DMD and other rare diseases. they conduct clinical research to continue validating patient outcomes with endpoints.
NS PHARMA
Industry:
Health Care Medical Pharmaceutical
Founded:
1999-01-01
Address:
Paramus, New Jersey, United States
Country:
United States
Website Url:
http://www.nspharma.com
Total Employee:
51+
Status:
Active
Contact:
+1 866 677 4276
Email Addresses:
[email protected]
Similar Organizations
American Pharmacies
American Pharmacies is a pharmaceutical company.
Forte Bio-Pharma
Forte Bio-Pharma is a pharmaceutical company.
Lederle International
Lederle International is a pharmaceuticals company
Peak Pharmacy
Peak Pharmacy is a pharmaceutical company.
StellaPharma
StellaPharma is a Pharmaceutical company
Official Site Inspections
http://www.nspharma.com
- Host name: ec2-54-234-103-72.compute-1.amazonaws.com
- IP address: 54.234.103.72
- Location: Ashburn United States
- Latitude: 39.0481
- Longitude: -77.4728
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20149
More informations about "NS Pharma"
NS Pharma - Building A Healthier Future Powered by Science
We are a highly focused, research-driven biopharmaceutical company working in rare diseases. Our current goal is to optimize the potential of exon-skipping therapy in treating Duchenne …See details»
Who we Are - NS Pharma
We are working with leading rare disease advocacy organizations to help facilitate access to treatments such as exon-skipping therapy and patient support. NS Pharma is dedicated to improving patient outcomes and raising the bar in the …See details»
Pipeline Developments - NS Pharma
NS Pharma inc has been focused on developing the NS-018 compound for the treatment of myelofibrosis and NS-065/NCNP-01 for Duchenne muscular dystrophy.See details»
NS Pharma - Crunchbase Company Profile & Funding
NS Pharma is a pharmaceuticals company. NS Pharma Develops treatments that offer value to those living with DMD and other rare diseases. they conduct clinical research to continue …See details»
NS Pharma opens new U.S drug discovery center in Cambridge, MA
PARAMUS, N.J., Jan. 6, 2023 /PRNewswire/ -- NS Pharma announced today the opening of a new office in Cambridge, Massachusetts, to establish the NS Pharma Innovation Research …See details»
NS Pharma’s VILTEPSO™ (viltolarsen) injection Now
Aug 12, 2020 · CureDuchenne is thrilled to relay the news that NS Pharma has received FDA marketing authorization for Vitolarsen, an exon 53 skipping therapy. The entire Duchenne community is grateful for NS Pharma’s dedication. …See details»
NS Pharma Shares Preliminary Results of Viltolarsen (NS-065 / …
May 27, 2024 · NS Pharma, Inc. (NS Pharma), a subsidiary of Nippon Shinyaku Co., Ltd., announced today that it has received preliminary analysis results from the global Phase 3 …See details»
NS Pharma - Craft
NS Pharma (NSP) is a company that specializes in the development and distribution of drugs. It is also engaged in clinical studies and develops NS-018 and NS-065/NCNP-01 drug candidates …See details»
NS Pharma, Inc. Shares New VILTEPSO® (Viltolarsen) Data at the …
Mar 6, 2024 · NS Pharma, Inc. (NS Pharma) is excited to announce participation in the 2024 Muscular Dystrophy Association (MDA) Clinical & Scientific Conference in Orlando, Florida, …See details»
NS Pharma Announces Research Alliance with MiNA Therapeutics …
Apr 4, 2024 · NS Pharma, Inc. (NS Pharma) announced that its parent company, Nippon Shinyaku Co., Ltd. (Nippon Shinyaku) – headquartered in Kyoto, Japan, entered into a joint …See details»
Join The Team - NS Pharma Careers
View a list of current job opportunities available at NS Pharma. Visit our careers page and apply for open positions online.See details»
NS Pharma Announces Receipt of Orphan Drug Designation from …
Dec 20, 2022 · NS Pharma, Inc., is a wholly owned subsidiary of Nippon Shinyaku Co., Ltd. For more information, please visit http://www.nspharma.com. NS Pharma is a registered …See details»
NS Pharma Inc. | Paramus NJ - Facebook
NS Pharma Inc., Paramus, New Jersey. 140 likes · 696 talking about this. We are a highly focused, research-driven biopharmaceutical company working in...See details»
NS Pharma Announces Research Alliance with MiNA Therapeutics …
PARAMUS, N.J., April 4, 2024 /PRNewswire/ -- NS Pharma, Inc. (NS Pharma) announced that its parent company, Nippon Shinyaku Co., Ltd. (Nippon Shinyaku) – headquartered in Kyoto, …See details»
NS Pharma, Inc. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for NS Pharma, Inc. of Paramus, NJ. Get the latest business insights from Dun & Bradstreet.See details»
NS Pharma Announces First Patient Enrolled in Phase 2 Study to …
PARAMUS, N.J., Feb. 17, 2023 /PRNewswire/ -- NS Pharma, Inc. announced today the first patient enrollment in a Phase 2 clinical study of NS-018 (ilginatinib), an investigational …See details»
NS Pharma - Building A Healthier Future Powered by Science
NS Pharma is a highly focused, research-driven biopharmaceutical company working in rare diseases.See details»
NS PHARMA
We strive to be at the forefront of healthcare advancements, fostering a future where everyone has access to quality and transformative pharmaceutical solutions. Patient-Centricity: Prioritize …See details»
NS Pharma - Building A Healthier Future Powered by Science
In the normal course of business, NS Pharma, Inc. including its parent, subsidiary or partner companies (collectively “NS Pharma”) may collect personal information that it uses to Help …See details»
NS Pharma Shares Preliminary Results of Viltolarsen (NS-065 / …
PARAMUS, N.J., May 27, 2024 /PRNewswire/ -- NS Pharma, Inc. (NS Pharma), a subsidiary of Nippon Shinyaku Co., Ltd., announced today that it has received preliminary analysis results …See details»